HistoIndex EASL 2024
Breakfast Meeting

The HistoIndex Breakfast Meeting at the European Association for the Study of the Liver (EASL) 2024 conference in Milan brought together leading experts in hepatology to discuss cutting-edge developments in Metabolic Dysfunction-Associated Steatohepatitis (MASH) research and treatment.

Highlights of the meeting included:

1. Presentation by Prof. Jonathan A. Fallowfield on the relationship between fibro-spatial and ballooning-based indices and clinical outcomes in MASH patients. This talk shed new light on the importance of quantitative assessments in predicting long-term patient outcomes.
2. Dr. Dean Tai’s introduction of qBallooning, an AI-powered tool for detecting ballooned hepatocytes. This innovative technology promises to enhance the accuracy and consistency of MASH diagnosis and treatment evaluation.
3. An engaging panel discussion on “The Evolving Role of Liver Biopsies” featuring renowned experts in the field. The panel explored the continued importance of liver biopsies in both clinical management and drug development for MASH.
4. Insights into the latest guidelines from AGA and AASLD, emphasizing the complementary roles of non-invasive tests (NITs) and liver biopsies in MASH diagnosis and management.

The event provided a unique opportunity for attendees to gain exclusive insights into the latest advancements in MASH research and treatment. Participants left with a deeper understanding of the potential of AI and digital pathology in personalizing treatment options for patients. HistoIndex continues to be at the forefront of innovation in liver disease research, fostering collaboration and knowledge-sharing among industry leaders. Stay tuned for future events where we’ll continue to explore groundbreaking developments in hepatology.